omniture
Ainos, Inc.

Latest News

Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals

VELDONA® interferon-alpha formulation has shown potential as a treatment candidate for feline chron...

2022-11-21 18:30 1572

Ainos Reports Unaudited Third Quarter 2022 Financial Results

Revenues increased by 384% year over year Debt ratio decreased to 7% from 75% at year-end 2021 SAN...

2022-11-07 20:30 2201

Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon Formulation

The FDA gave positive feedback regarding filing a Biologics License Application (BLA) for Sjögren's...

2022-11-03 19:00 1542